Dr. Gabriel Pardo

Director of the OMRF Multiple Sclerosis Center of Excellence, where MS is approached with optimal clinical care and scientific innovation. Opinions are my own.

[Dr. Gabriel Pardo @DocforMS]

Celebrating #WorldMSday 2026 by giving our #MS warriors a creative space. Working -with soul and science- for a better future @OMRF

[Dr. Gabriel Pardo @DocforMS]

@MSViewsandNews @OMRF Happy to

[Dr. Gabriel Pardo @DocforMS]

Innovative ways to assess disease status and progression in #MS is an unmet need. Proud of our team's work using eye movement analysis as a way to assess cognition and correlate with functional and anatomical metrics @OMRF https://t.co/PRYbHY2IqG

[Joe Sabatino @jsabatino37]

EBV is required for the development of multiple sclerosis, but it’s not known how a common virus leads to disease. 3 exciting new papers in @CellCellPress provide major insights into how this may occur:

[Dr. Gabriel Pardo @DocforMS]

Six-year safety and efficacy outcomes with first-line ofatumumab in re... https://t.co/mU6nC5AByZ
Exploring longterm effects of early initiation of highly effective treatment as first line in MS; positive data!

[Barry Singer MD 🧠 @drbarrysinger]

Repairing MS: The Quest to Rebuild Myelin
New MS Living Well Podcast🎙️Guests: Veronique Miron PhD🇨🇦 @UofT & Rob Glanzman MD 🇺🇸
https://t.co/KR1OFBFsKS 🍏https://t.co/40rbJ3RRAJ
@MSCanOfficial @DrJim4MS @MStranslate @DocforMS @DrJNicholas Sponsor: @TGTherapeutics

[Barry Singer MD 🧠 @drbarrysinger]

#ECTRIMS2025 coming up in Sept. 24-26 in Barcelona. Off to Toronto, Canada in 2026! ⛸️ Advances in #MS🌲#ECTRIMS2026! 🇨🇦
@AlexMuccilli @MSDoc_Freedman @DocforMS @DrJNicholas @Brandon_Beaber @C_OrejaGuevara @KlausSchmierer @J_SastreGarriga @bart_professor @anneke_vdw @ECTRIMS

[Barry Singer MD 🧠 @drbarrysinger]

🚀Boosting Brain Health: Blueprint for MS
New MS Living Well Podcast 🎧🚶‍♀️🥗😴🧘‍♀️
https://t.co/O8eOHfst0c🍏https://t.co/ROmDTLBQng
@KlausSchmierer @DocforMS @anneke_vdw @C_OrejaGuevara @ahmedzobeidat @bart_professor Sponsor: @TGTherapeutics

[Dr. Gabriel Pardo @DocforMS]

Want to learn more about visual involvement in MS? Watch this: Bringing MS Vision Problems Into Focus - Can Do MS. https://t.co/VPprZuERiW

[Dr. Gabriel Pardo @DocforMS]

Advocacy in action! Fearless Lea Campbell obtained -again- a Governor’s proclamation making March the #NMOSD month in Oklahoma. #MOGAD #raredisease @guthyjacksonfdn @TheSumairaFDN @OMRF

[Practical Neurology @PracticalNeuro]

How can functional, anatomic, and biologic tools optimize treatment and risk mitigation for people with progressive #multiplesclerosis? Read Dr. Pardo's (@DocforMS) review article in our February issue.
https://t.co/4qpSkovKgg

@OMRF @mscare @mssociety @AANmember @ACTRIMS @ACPIMPhysicians #MS

[Dr. Gabriel Pardo @DocforMS]

Proud to share ongoing work on novel approaches to quantifying #MS impact. @ViewMind_ Eye movement deficits in Multiple Sclerosis: characterizing executive ... https://t.co/uV9WS0YfcI

[Dr. Gabriel Pardo @DocforMS]

@pabear5 @Brandon_Beaber @OMRF @AaronBosterMD @drbarrysinger @MSViewsandNews @WHO Sure! It is because there is no prospective cohort on rituximab followed in a controlled manner started shortly after diagnosis and with close monitoring. What this teaches us is the long term benefits -and problems- of using highly effective therapy early on. We learn!

[Dr. Gabriel Pardo @DocforMS]

Happy to share this collaborative work looking at long term results of a high efficacy DMT in early #MS #ocrelizumab ⁦@OMRF⁩ ⁦⁦@AaronBosterMD⁩ ⁦@drbarrysinger⁩ ⁦@Brandon_Beaber⁩ ⁦@MSViewsandNews⁩ https://t.co/tTemxga7Qa

[Saisree Ravi, MD @SaisreeRaviMD]

Thought-provoking discussion about gaps in MS treatments and the role of microglia and CNS targeting therapies by @DocforMS at #TNSW2025 @Texas_Neuros

[Dr. Gabriel Pardo @DocforMS]

So happy to share the day, knowledge, and experiences with 400+ patients and caregivers at Dr. Khatri’s Living Well with #MS and Other Autoimmune Neurological Disorders in Milwaukee. #NMOSD #MOGAD @OMRF

[Dr. Gabriel Pardo @DocforMS]

Patient education day #NMOSD #MOGAD with the @guthyjacksonfdn in OKC. Committed to improving care and science of rare diseases

[Dr. Gabriel Pardo @DocforMS]

@GavinGiovannoni Farewell from the clinic …not an intelectual/science farewell. Plenty to sort out and happy to learn you will continue to pursue much needed answers. See you on the road!

[Dr. Gabriel Pardo @DocforMS]

@okudaMD Healthcare systems in US and globally must use medical providers , medications and infrastructure more rationally and equitably. We need to make an even bigger difference. #waste #healthcare

[Darin T. Okuda, M.D., M.Sc., F.A.A.N., F.A.N.A. @okudaMD]

Have you ever wondered about the magnitude of new/unused disease modifying therapies for multiple sclerosis that may be out there? Retail costs for these specialty medicines are near $100K per year!

This is a before and after photo from 2020. Imagine for a minute what we have collected up to present day.

Enthusiasm for fixing the problem is low especially when compensation has already occurred along the distribution chain.

@davidbalat @patientsrising @ectrims @actrims @mssociety @docforms @DrugChannels @elonmusk